GS‑441524 Injection is a highly effective antiviral treatment developed for cats diagnosed with Feline Infectious Peritonitis (FIP). As a nucleoside analog, GS‑441524 inhibits the replication of feline coronavirus (FCoV), which is the underlying cause of FIP. It is currently regarded as one of the most promising solutions for FIP therapy worldwide.
Formulated as a sterile injectable solution, our GS‑441524 is produced with ≥99.5% purity to ensure maximum bioavailability, safety, and stability. It is used in the treatment of various FIP types, including effusive (wet), non-effusive (dry), and neurological forms. Clinical improvement is often seen within 3–7 days of initiating treatment.
Concentration options: 20mg/mL or 30mg/mL
Packaging: 5mL or 10mL vials (customization available)
Typical treatment duration: 84 days (dosage varies by weight and severity)
| Parameter | Value |
|---|---|
| Specification | 20mg/mL, 30mg/mL |
| Product Shelf Life | 1 Year |
| Product Form | Injections |
| Product Packaging | 10 Vial Per Box |
| Shipping Method | Air(UPS, FedEx, TNT, EMS) Or Sea |
| Product Usage | Cat FIPV Treatment |
| Product Type | Liquid |
| Test Method | HPLC UV |
| Molecular Weight | C12H13N5O4 |
| Product Storage | Store In A Cool, Dry Place |
| Product Name | GS441 FIP Treatment |
| Product Characteristics | Cat FIP, Remdesivir intermediate |
Feline Infectious Peritonitis (FIP) is a fatal viral disease in cats caused by a mutation of the feline coronavirus (FCoV). While most cats infected with FCoV do not develop FIP, in some cases, the virus mutates and triggers an abnormal immune response, leading to FIP.
FCoV is common in multi-cat environments like shelters and catteries. The virus is primarily transmitted through fecal-oral contact, where cats ingest the virus from contaminated surfaces, litter boxes, or grooming each other.
Diagnosing FIP is challenging and often involves a combination of clinical signs, laboratory tests, and ruling out other diseases. Common diagnostic steps include:
1. Blood tests: Elevated protein levels, high white blood cell count, and low albumin-to-globulin ratio.
2. Imaging: Ultrasound or X-rays to detect fluid accumulation.
3. Fluid analysis: Testing the fluid from the abdomen or chest for elevated protein levels and specific cell types.
4. Biopsy: Histopathological examination of affected tissues can provide a definitive diagnosis.
Packing: 1 box * 10 vials
Recommended treatment: 12 weeks.
Recommended dosage:*DOSAGE IS BASED ON THE WEIGHT AND SYMPTOMS*
Ascites / pleural effusion: 0.5mL/kg * body weight kg + 0.1 residue
FIP(Wet):0.4mL/kg * body weight kg + 0.1 residue
FIP(Dry): 0.6mL/kg * body weight kg + 0.1 residue
Eye / nerve entry: 0.7mL/kg * body weight kg + 0.1 residue
Recurrence: 0.9 mL/ kg * body weight kg + 0.1 residue
Storage
Store at room temperature or Store at 2~4 ° C (Better). Avoid light. Shelf life is one year.
Do not place in a sub-zero environment. Because this will result in the precipitation of active ingredients and the appearance of crystals, thus affecting the concentration and therapeutic effect.
GS‑441524 is generally well-tolerated, but the following precautions are advised:
Injection site reactions: Mild swelling or pain may occur.
Organ monitoring: Regular blood tests for liver and kidney function are recommended.
Storage: Keep the injectable solution at 2–8°C (refrigerated), away from light.
⚠️ Never use for human treatment. Veterinary use only.
